NeurogesX Receives $684,300 New Financing

  • Feed Type
  • Date
    11/27/2012
  • Company Name
    NeurogesX
  • Mailing Address
    2215 Bridgepointe Parkway San Mateo, CA 94404
  • Company Description
    NeurogesX is a privately held specialty pharmaceutical company focusing on the development novel treatments for improved relief of neuropathic pain and improved quality of life for neuropathic pain patients using advanced neuroscience insights and innovative delivery technologies.
  • Website
    http://www.neurogesx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $684,300
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount included options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.